Shawn Titcomb
InvestorInvestor at Allele Capital Partners
Fort Lauderdale, Florida
Writes $100K – $5M checks · typically $1.5M
About
Shawn Titcomb is Co-Founder and CEO of the Allele Companies, which includes Allele Capital, Allele Ventures, and Allele Communications, and serves as Co-Founder and Executive Chairman of Majesty Therapeutics. With over 20 years of capital markets experience, he has advised more than 100 companies on financing, investor relations, and strategic transactions, resulting in over $4 billion in secured financing and more than 15 exits. His background includes previous roles as Head of Investment and Merchant Banking at Noble Life Science Partners, Founding Partner at Variant Research Corporation, and Senior Vice President at Avalon Research Group.
Experience
- Majesty TherapeuticsCo-Founder and Executive Chairmancurrent2024 — presentUnited States
- Allele CapitalCo-Founder and CEOcurrent2017 — presentLauderdale-by-the-Sea, Florida, United States
- Allele CommunicationsCo-Founder and CEOcurrent2022 — presentLauderdale-by-the-Sea, Florida, United States
- Praesidia BiotherapeuticsMember Board Of Directorscurrent2021 — presentArlington, Massachusetts, United States
- NOBLE Capital MarketsHead of Investment and Merchant Banking, Noble Life Science Partners2006 — 2017Boca Raton, Florida and New York, New York
- Variant ResearchFounding Partner2003 — 2006
- Avalon Research GroupSr. Vice President, Institutional Research Sales2000 — 2003
Education
- University of DenverBS, Business Administration1990 — 1994
Skills & more
+8 more
EquitiesFinancial StructuringIPOFinanceStart-upsMergers & AcquisitionsDue DiligenceStrategic PlanningFrom Shawn's professional profile.
Same school
Also attended University of Denver34
+ 28 more
Shared employers
Also worked at Allele Communications1
Colleagues at Allele Capital Partners
Network2
Investors connected to Shawn in public investor directories — a warm-intro map.